Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain – relation to brain concentration
- 1 December 2006
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 51 (7-8) , 1163-1171
- https://doi.org/10.1016/j.neuropharm.2006.07.018
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- How to measure drug transport across the blood-brain barrierNeuroRX, 2005
- NAAG Reduces NMDA Receptor Current in CA1 Hippocampal Pyramidal Neurons of Acute Slices and Dissociated NeuronsNeuropsychopharmacology, 2004
- The cloning and characterization of a second brain enzyme with NAAG peptidase activityJournal of Neurochemistry, 2004
- Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemiaEuropean Journal of Pharmacology, 2002
- Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cellsNeuroscience, 1998
- Glutamate and N-acetylaspartylglutamate block HVA calcium currents in frog olfactory bulb interneurons via an mGluR2/3-like receptorJournal of Neurophysiology, 1996
- Brain MicrodialysisJournal of Neurochemistry, 1989
- Hydrolysis of the Brain Dipeptide N‐Acetyl‐l‐Aspartyl‐l‐Glutamate: Subcellular and Regional Distribution, Ontogeny, and the Effect of Lesions on N‐Acetylated‐α‐Linked Acidic Dipeptidase ActivityJournal of Neurochemistry, 1988
- A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in manPain, 1988
- Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.Stroke, 1986